跳至主要内容
临床试验/CTRI/2023/10/058799
CTRI/2023/10/058799招募中4 期

Efficacy of oral torsemide versus oral furosemide in management of edema in patients with nephrotic syndrome: an open-label superiority randomized controlled trial - NI

Dr Tanvi Bindal0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Idiopathic nephrotic syndrome at onset or in relapse state
  • 2. 3 to 18-year-old, toilet trained
  • 3. Moderate to severe edema (judged clinically)

排除标准

  • 1. Secondary cause of nephrotic syndrome
  • 2. Presence of hypovolemia
  • 3. Unable to swallow tablet
  • 4. Serum albumin <1.5 g/dl
  • 5. Acute kidney injury (AKI)
  • 6. Chronic kidney disease with eGFR <60 ml/min per 1.73 m2
  • 7. Hypokalemia, hyponatremia or significant
  • metabolic alkalosis or acidosis
  • 8. Use of IV albumin in the last 48 hours
  • 9. Use of oral/IV diuretic in the last 24 hours
  • 10. Diarrhea or vomiting in the last 48 hours
  • 11. Suspected or confirmed thrombosis
  • 12. Previously enrolled in the same study

研究者

发起方
Dr Tanvi Bindal

相似试验